Richard Ashworth

DEERFIELD, Ill. — Walgreens announced a new collaboration with Susan G. Komen and the Leukemia & Lymphoma Society (LLS) to enable research in tough-to-treat cancers and increase access to care with a pledge to contribute more than $25 million to the organizations, collectively, over the next five years. Through a combination of corporate donations and in-store fundraising, the commitment will enable new research in metastatic breast and pediatric blood cancers, as well as increase access, treatment and support services for those living with these diseases.

“At Walgreens, we see the devastating impact of a cancer diagnosis and the challenges people living with cancer and their caregivers face in one of the toughest journeys of their lives,” said Walgreens president of operations Richard Ashworth. “By collaborating with Susan G. Komen and the Leukemia & Lymphoma Society, we aim to advance critical needs in research, expand prevention programs and help families with the everyday challenges of living with cancer.”

Walgreens customers can get involved by donating to the organizations during checkout at the more than 9,500 U.S. Walgreens retail pharmacy locations November 3 through November 17. LLS and Susan G. Komen are committed to supporting patient services and increasing access to screening and treatments locally and nationally. All donations Walgreens receives in November will be split equally between the two organizations.

“Susan G. Komen is thankful for the support of Walgreens and their customers and excited about the potential of this collaboration to accelerate the pace of research discovery, particularly as it relates to understanding and combating why breast cancers recur and become metastatic,” said Paula Schneider, chief executive officer of Susan G. Komen. “Thanks to this partnership, we will be able to help support people touched by breast cancer today, while we spur the development of more effective treatments.”

Louis DeGennaro, president and CEO of LLS, commented, “Our partnership with Walgreens is setting a new standard for what nonprofits and industry can do through collaboration to help more patients.”